HomeARQT • NASDAQ
add
Arcutis Biotherapeutics Inc
Previous close
$24.01
Day range
$23.52 - $24.55
Year range
$8.98 - $27.08
Market cap
2.98B USD
Avg Volume
2.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 99.22M | 121.69% |
Operating expense | 82.01M | 4.71% |
Net income | 7.41M | 117.84% |
Net profit margin | 7.47 | 108.05% |
Earnings per share | 0.06 | 118.18% |
EBITDA | 9.09M | 124.05% |
Effective tax rate | 1.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 191.07M | -42.20% |
Total assets | 370.98M | -15.18% |
Total liabilities | 212.90M | -24.16% |
Total equity | 158.07M | — |
Shares outstanding | 122.49M | — |
Price to book | 18.33 | — |
Return on assets | 5.89% | — |
Return on capital | 8.18% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 7.41M | 117.84% |
Cash from operations | -1.75M | 94.94% |
Cash from investing | -25.25M | -129.78% |
Cash from financing | 1.48M | 274.62% |
Net change in cash | -25.62M | -150.65% |
Free cash flow | -6.36M | 61.84% |
About
Founded
2016
Headquarters
Website
Employees
342
